Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Most cough, cold and allergy (hay fever) remedies categories in Hungary are set to expand in volume terms in 2023 or record slower rates of decline than in 2022. Similar to the case with analgesics, the need for these products has been bolstered by…
In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…
Although the pandemic is considered over, this is not expected to immediately reduce sales of OTC cough and cold medicines in Indonesia in 2023, with both retail volume and current value growth set to continue across most categories. However, the…
Cough, cold and allergy (hay fever) remedies are enjoying strong growth in 2023 as the category continues to recover from the sharp declines seen during the COVID-19 pandemic. Flu, common coughs and colds and seasonal allergies in the Irish…
The normalisation of consumer lifestyles has hastened the return of common coughs and cold in Israel, with a notable uplift in schools. In April 2022, the mask mandate was removed, aside from specific locations such as hospitals and medical clinics,…
Cough/cold remedies are set to see high single-digit growth in current value terms in 2023, with sales likely to benefit from a high number of cases of cold and flu in the 2023/2024 season. Furthermore, value sales will likely also be boosted by unit…
Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…
Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…
A prevalent issue in cough, cold and allergy (hay fever) remedies is the misuse of cough syrups, often through self-medication with OTC products. To address this concern, a regulatory framework has been implemented restricting the distribution of…
Cough, cold and allergy (hay fever) remedies in Latvia is registering moderate growth in 2023 as the category begins to stabilise post-pandemic. Retail value sales rebounded strongly 2022 after two years of decline, with lifestyles shifting back to…
2023 marks the year when the cough and cold landscape is set to lose its uplift due to COVID-19, returning to a level closer to that seen pre-pandemic. Sales have continued to benefit from harsh seasonal colds and the flu season of 2022-2023.…
Cough, cold and allergy (hay fever) remedies witnessed an improved performance in constant value terms in 2023. This was due, in a large part, to a return of pre-pandemic lifestyles, including the reopening of schools and workspaces, which…
In early 2023, a sixth wave of COVID-19 coincided with an upsurge in cases of the common cold and influenza, creating a "tripledemic" felt across Mexico, the US, and Central American countries, with Mexico experiencing a milder impact. This scenario…
Overall demand for cough and cold remedies in Morocco has picked up in 2023, with most categories set to register improved results in volume growth terms as compared to 2022. The use of these products has been buoyed by the easing of the pandemic and…
With an early start to the influenza season, many New Zealanders were caught off guard and succumbed to the virus throughout 2023. With a dry cough being one of the most common flu symptoms, demand for treatments to help soothe the throat was…
On a landscape featuring local and international brands, consumers can access a wide array of choices. Brands like Emzolyn and Exiplon are popular among individuals with lower disposable incomes, while international counterparts, including Benylin,…
Cough, cold and allergy (hay fever) remedies is seeing slower growth in 2023 due to a shorter cold season caused by milder winter 2022/2023. The exception is antihistamines, which continues to grow at a solid rate due to high consumer demand amidst…
Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered…
As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…
Consumers have been returning to doctors’ surgeries in the post-pandemic landscape, thus hindering the sales of OTC medicines which they are instead accessing via prescription. This is noted to be the case with antihistamines, for example, along with…